Skip to main content
. Author manuscript; available in PMC: 2016 Mar 6.
Published in final edited form as: Eur J Med Chem. 2014 Dec 29;92:212–220. doi: 10.1016/j.ejmech.2014.12.050

Table 3.

Anti-leukemic activity (LD50) of the most potent compounds against the MV4-11 AML cell line

Compound
8 11 12 13 14 15 16 17
LD50 (μM) 0.044 0.369 0.047 >20 1.169 0.233 1.223 4.339
Compound
21 22 23 24 25 29 30 31
LD50 (μM) 0.565 >20 0.375 0.467 4.529 0.018 6.063 0.180